Holen Sie sich die Stockscreener-App
1.53
1.30%
0.01
Schlusskurs vom Vortag:
$1.54
Offen:
$1.54
24-Stunden-Volumen:
13,676
Relative Volume:
0.12
Marktkapitalisierung:
$8.64M
Einnahmen:
$125.00K
Nettoeinkommen (Verlust:
$-14.64M
KGV:
-0.2961
EPS:
-5.1674
Netto-Cashflow:
$-15.06M
1W Leistung:
+0.00%
1M Leistung:
-3.11%
6M Leistung:
-50.00%
1J Leistung:
-73.20%
1-Tages-Spanne:
$1.50
$1.5673
1-Wochen-Bereich:
$1.50
$1.5951
52-Wochen-Spanne:
$1.47
$5.89
Imunon Inc Stock (IMNN) Company Profile
Firmenname
Imunon Inc
Sektor
Branche
Telefon
(609) 896-9100
Adresse
997 LENOX DRIVE, LAWRENCEVILLE
Compare IMNN vs VRTX, REGN, ARGX, MRNA, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IMNN
Imunon Inc
|
1.54 | 8.64M | 125.00K | -14.64M | -15.06M | -5.1674 |
VRTX
Vertex Pharmaceuticals Inc
|
522.11 | 134.06B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
803.76 | 83.43B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,004.25 | 63.00B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
137.30 | 56.02B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
209.67 | 44.44B | 742.00K | -1.37B | -1.07B | -7.0731 |
Imunon Inc Aktie (IMNN) Neueste Nachrichten
Imunon schedules R&D day for Sept. 23 to discuss IL-12 therapy - Investing.com UK
IMUNON Announces Full Agenda and Speaker Lineup Ahead of - GlobeNewswire
Imunon (IMNN) Slips 2.5% to $1.56 as Range-Bound Trading Keeps Key Levels in FocusCharm Flow - siam.in
IMNN|Imunon Inc|Price:1.560| - TradingKey
Imunon Inc (IMNN) Insider Sell: General Counsel and Corp Sec Susan Eylward Sells 2,525 Shares - GuruFocus
Insider at Imunon (NASDAQ: IMNN) logs new stock trade - Stock Titan
Imunon (IMNN) insider reports new stock trade - Stock Titan
Imunon (IMNN) counsel takes salary in stock, then sells the same number of shares days later - Stock Titan
Imunon Inc (NASDAQ: IMNN) Share Price, IMNN Stock News, IMNN Share Price & Updates - Kalkine
Imunon to host R&D day on phase 3 ovarian cancer trial - Investing.com Canada
Imunon to host R&D day on Sept. 23 for ovarian cancer therapy - Investing.com India
IMUNON to Host 2026 R&D Day Highlighting Phase 3 OVATION 3 Trial and the Clinical Potential of IMNN-001 - Yahoo Finance
Imunon (IMNN) Q2 2026 Results: The Available Earnings Metric Delivers a Beat on the Day; After Earnings: The Stock Records a 3.80% Increase in the Current UpdateQuarterly Profit Report - vinanet.vn
Imunon Earnings Call Highlights Survival Gains, Cash Needs - TipRanks
Imunon (IMNN) Q2 2026 Filing Snapshot: The Bottom-Line Figure Outpaces Its Comparison in the Latest Session; Stock Move: Shares Move 1.25% Lower on the DayEarnings Revision Upgrade - vinanet.vn
Imunon (IMNN) General Counsel and Corp Sec Susan Eylward Sells 2,449 Shares - GuruFocus
Imunon (IMNN) pays executive chair with 7,147 shares - Stock Titan
Imunon (IMNN) CEO takes 6,615 shares instead of cash pay - Stock Titan
Imunon (IMNN) pays CMO with 3,516-share stock grant - Stock Titan
Imunon (IMNN) counsel gets stock in lieu of pay, then sells 2,449 shares - Stock Titan
Imunon (IMNN) Q2 2026 Earnings: Narrower-Than-Expected Loss Drives 4.43% BounceProduct Revenue Analysis - vinanet.vn
Imunon Inc. (IMNN) Advances 4.43% as Biotech Stock Tests Key Resistance at $1.73Fair Value Gap - dars.gov.et
Armistice Capital (IMNN) discloses 9.99% Imunon stake via Master Fund - Stock Titan
IMUNON to Hold First Quarter 2025 Financial Results and Business Update Conference Call on Monday, May 12, 2025 - kalkine.ca
Earnings call transcript: Imunon beats Q2 2026 EPS forecast as shares stay weak - Investing.com UK
Maxim Group Maintains Imunon(IMNN.US) With Buy Rating, Maintains Target Price $10 - Moomoo
Imunon (IMNN) Q2 2026 Earnings Call Transcript - The Globe and Mail
Imunon Q2 2026 Loss Shrinks 42.6%: -$0.54/Share vs -$0.94 Expected - AlphaStreet
Imunon Q2 2026 Earnings Call Transcript - MarketBeat
Imunon Adopts New Equity-Based Executive Compensation Program - TipRanks
Imunon, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Imunon, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Form 8K Imunon Inc For: 11 August By Investing.com - Investing.com Australia
Q2 2026 Imunon Inc Earnings Call Transcript - GuruFocus
Imunon Inc (IMNN) Advances Phase 3 Trial Amidst Challenging Valu - GuruFocus
Imunon, Inc. 2Q 2026: Net loss $(2.83M), EPS $(0.54) — 10-Q Summary - TradingView
IMUNON Reports Second Quarter 2026 Financial Results and Provides Business Update - The Manila Times
Imunon Q2 net loss widens slightly as R&D costs rise - tradingview.com
IMUNON reports $2.8 million Q2 loss as OVATION 3 enrollment advances - Quiver Quantitative
Imunon reports Q2 2026 net loss $2.8M; cash $6.9M, advances Phase 3 OVATION 3 - TradingView
BRIEF-Imunon Q2 EPS USD -0.54 - TradingView
IMNN Q2 2026 Earnings: EPS Loss of $0.54 Beats Estimates by 42.83%; Stock Rises 0.61Quarterly Earnings Report - vinanet.vn
IMNN Q1 2026 Earnings: Narrower-Than-Expected Loss of -$0.84 Beats Estimates; Shares Rise 3.19%Return On Capital - vinanet.vn
Imunon Inc expected to post a loss of 93 cents a shareEarnings Preview - TradingView
Imunon Inc. (CBO0.SG) cash flow - Yahoo Finance UK
Imunon (IMNN.US) will release its earnings report on August 11. - Moomoo
Imunon (IMNN) General Counsel Susan Eylward Sells 2,541 Shares - GuruFocus
Imunon, Inc. (IMNN) director granted 6,934 shares in lieu of fees - stocktitan.net
Imunon (IMNN) director granted 6,934 shares of stock for board fees - Stock Titan
Imunon (IMNN) grants director 6,934 shares instead of cash board fees - Stock Titan
Imunon (NASDAQ: IMNN) awards director 6,180 shares for board fees - Stock Titan
Finanzdaten der Imunon Inc-Aktie (IMNN)
Umsatz
Nettogewinn
Free Cashflow
ENV
Imunon Inc-Aktie (IMNN) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Eylward Susan | General Counsel and Corp Sec |
Aug 17 '26 |
Sale |
1.63 |
2,449 |
3,993 |
2,896 |
| Eylward Susan | General Counsel and Corp Sec |
Aug 03 '26 |
Sale |
1.57 |
2,541 |
3,977 |
2,896 |
| Eylward Susan | General Counsel and Corp Sec |
Jul 20 '26 |
Sale |
1.78 |
2,150 |
3,830 |
2,896 |
| Eylward Susan | General Counsel and Corp Sec |
Jul 06 '26 |
Sale |
1.88 |
920 |
1,730 |
2,896 |
| Eylward Susan | General Counsel and Corp Sec |
Jun 29 '26 |
Sale |
1.75 |
11,800 |
20,674 |
2,896 |
0.63%
3.49%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):